A ‘perfect storm’ of world calamities may bring down drug prices, Takeda CEO saysnews2022-06-02T01:07:23+00:00June 2nd, 2022|Fierce Pharma|
Biogen, Samsung Bioepis launch first US biosimilar, a copycat of Roche’s Lucentis, at 40% discountnews2022-06-01T17:11:02+00:00June 1st, 2022|Fierce Pharma|
FDA puts Sanofi’s Cialis prescription-to-OTC trial on hold, citing problems with study’s designnews2022-06-01T15:35:44+00:00June 1st, 2022|Fierce Pharma|
After flagging death risks, FDA rescinds accelerated approval for TG Therapeutics’ Ukoniqnews2022-06-01T15:26:39+00:00June 1st, 2022|Fierce Pharma|
Regeneron’s cholesterol drug war heats up with lawsuit over Amgen’s ‘illegal’ bundling schemenews2022-06-01T14:04:35+00:00June 1st, 2022|Fierce Pharma|
Novartis’ Sandoz boosts biosimilars awareness with new ‘Act4Biosimilars’ campaignnews2022-06-01T12:12:24+00:00June 1st, 2022|Fierce Pharma|
Pfizer, already flush with cash, will reap $16B from selling shares in GSK consumer health spinoffnews2022-06-01T11:40:51+00:00June 1st, 2022|Fierce Pharma|
Who needs Humira? AbbVie projected to be the top pharma company by sales in 2028: analystsnews2022-06-01T10:51:06+00:00June 1st, 2022|Fierce Pharma|
Pfizer topples oncology giant Roche in cancer patient groups’ reputation listnews2022-06-01T08:34:48+00:00June 1st, 2022|Fierce Pharma|
Former AstraZeneca exec charged with insider trading in Daiichi Sankyo’s licensing dealnews2022-05-31T20:48:27+00:00May 31st, 2022|Fierce Pharma|
